Vetoshkina T V, Fomina T I
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Bull Exp Biol Med. 2003 Jan;135 Suppl 7:88-90. doi: 10.1023/a:1024799217693.
Ultralow doses of antibodies to cholecystokinin prevented hepatocyte death, delayed the formation of the connective tissue, and normalized plasma of liver enzyme in rats with experimental acute and chronic toxic hepatitis.
超小剂量的胆囊收缩素抗体可防止实验性急慢性中毒性肝炎大鼠的肝细胞死亡，延缓结缔组织形成，并使肝酶血浆水平恢复正常。
